p.119 抽出テキスト

opathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428. PMID: 7196689 355. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437-444. PMID: 6683731 356. Kawano M, Takenaka T, Otsuji Y, et al. Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry’s disease. Am J Cardiol 2007; 99: 261-263. PMID: 17223430 357. Yuasa T, Takenaka T, Higuchi K, et al. Fabry disease. J Echocardiogr 2017; 15: 151-157. PMID: 28674962 358. Liu H, Pozios I, Haileselassie B, et al. Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. Am J Cardiol 2017; 120: 670-675. PMID: 28687124 359. Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998; 81: 1339-1344. PMID: 9631972 360. Maron BJ, Spirito P, Green KJ, et al. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987; 10: 733-742. PMID: 3655141 361. Ro R, Halpern D, Sahn DJ, et al. Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve. J Am Coll Cardiol 2014; 64: 1984-1995. PMID: 25440093 362. Sherrid MV, Balaram S, Kim B, et al. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. J Am Coll Cardiol 2016; 67: 1846-1858. PMID: 27081025 363. Silbiger JJ. Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights. J Am Soc Echocardiogr 2016; 29: 622-639. PMID: 27146120 364. Shah PM, Taylor RD, Wong M. Abnormal mitral valve coaptation in hypertrophic obstructive cardiomyopathy: proposed role in systolic anterior motion of mitral valve. Am J Cardiol 1981; 48: 258-262. PMID: 7196686 365. Sherrid MV, Chu CK, Delia E, et al. An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 816-825. PMID: 8354817 366. Sherrid MV, Gunsburg DZ, Moldenhauer S, et al. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2000; 36: 1344- 1354. PMID: 11028493 367. Stewart WJ, Schiavone WA, Salcedo EE, et al. Intraoperative Doppler echocardiography in hypertrophic cardiomyopathy: correlations with the obstructive gradient. J Am Coll Cardiol 1987; 10: 327-335. PMID: 3598004 368. Sasson Z, Yock PG, Hatle LK, et al. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol 1988; 11: 752-756. PMID: 3351141 369. Suzuki K, Akashi YJ. Exercise stress echocardiography in hypertrophic cardiomyopathy. J Echocardiogr 2017; 15: 110-117. PMID: 28501918 370. Jan MF, Todaro MC, Oreto L, et al. Apical hypertrophic cardiomyopathy: Present status. Int J Cardiol 2016; 222: 745-759. PMID: 27521551 371. Minami Y, Haruki S, Hagiwara N. Phenotypic overlap in hypertrophic cardiomyopathy: apical hypertrophy, midventricular obstruction, and apical aneurysm. J Cardiol 2014; 64: 463-469. PMID: 24768408 372. Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. J Am Coll Cardiol 2017; 69: 761-773. PMID: 28209216 373. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-842. PMID: 8598070 374. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816. PMID: 16567565 375. Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002; 144: 524-529. PMID: 12228791 376. Otsuji Y, Levine RA, Takeuchi M, et al. Mechanism of ischemic mitral regurgitation. J Cardiol 2008; 51: 145-156. PMID: 18522789 377. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Re- sponse to CRT (PROSPECT) trial. Circulation 2008; 117: 2608-2616. PMID: 18458170 378. Jansen AH, van Dantzig Jm, Bracke F, et al. Qualitative observation of left ventricular multiphasic septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after cardiac resynchronization therapy. Am J Cardiol 2007; 99: 966-969. PMID: 17398193 379. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299-302. PMID: 10426842 380. 日本循環器学会.循環器病ガイドラインシリーズ2016年度版:心臓サルコイドーシスの診療ガイドライン.https://www.j-circ.or.jp/ cms/wp-content/uploads/2020/02/JCS2016_terasaki_h.pdf 381. Otto CM. The practice of clinical echocardiography. Elsevier - Health Sciences Division, 2017. 382. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63: 86-108. PMID: 327806 383. González-López E, Gallego-Delgado M, Guzzo-Merello G, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015; 36: 2585-2594. PMID: 26224076 384. Di Bella G, Pizzino F, Minutoli F, et al. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. Eur Heart J Cardiovasc Imaging 2014; 15: 1307-1315. PMID: 25190073 385. 日本循環器学会.2020年版心アミロイドーシス診療ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2020_ Kitaoka.pdf 386. Militaru S, Ginghina C, Popescu BA, et al. Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets. Eur Heart J Cardiovasc Imaging 2018; 19: 1313-1322. PMID: 30247528 387. Whybra C, Kampmann C, Krummenauer F, et al. The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 2004; 65: 299-307. PMID: 15025723 388. Imbriaco M, Pisani A, Spinelli L, et al. Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study. Heart 2009; 95: 1103-1107. PMID: 19372091 389. Pieroni M, Chimenti C, De Cobelli F, et al. Fabry’s disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol 2006; 47: 1663- 1671. PMID: 16631007 390. Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med 1995; 333: 288-293. PMID: 7596372 391. Rivenes SM, Kearney DL, Smith EO, et al. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000; 102: 876-882. PMID: 10952956 392. Katritsis D, Wilmshurst PT, Wendon JA, et al. Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 1991; 18: 1230-1235. PMID: 1918700 393. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone. J Am Coll Cardiol 1997; 30: 8-18. PMID: 9207615 394. Oh JK. Chapter 14: pericardial disease. In: Oh JK. The Echo Manual, 2nd edn. Lippincott-Raven, 1999: 181-194. 395. Tabata T, Kabbani SS, Murray RD, et al. Difference in the respiratory variation between pulmonary venous and mitral inflow Doppler velocities in patients with constrictive pericarditis with and without atrial fibrillation. J Am Coll Cardiol 2001; 37: 1936-1942. PMID: 11401135 396. Hancock EW. Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis. Heart 2001; 86: 343-349. PMID: 11514495 397. Schoenfeld MH, Supple EW, Dec GW Jr, et al. Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoracotomy. Circulation 1987; 75: 1012- 1017. PMID: 3568302 398. Rajagopalan N, Garcia MJ, Rodriguez L, et al. Comparison of new Doppler echocardiographic methods to differentiate constrictive pericardial heart disease and restrictive cardiomyopathy. Am J Cardiol 2001; 87: 86-94. PMID: 11137840 399. Sengupta PP, Krishnamoorthy VK, Abhayaratna WP, et al. Disparate patterns of left ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. JACC Cardiovasc Imaging 2008; 1: 29-38. PMID: 19356402